HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Krebs Biochemicals & Industries Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 26 filings·Updated 7 Aug 2026
Showing 10 of 26 filings.
7 Aug 20261 filing
Company UpdateNewspaper Publication

The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026

Filed 09:22View Source
6 Aug 20261 filing
ResultFinancial Results

Krebs Biochemicals & Industries approves unaudited Q1 2026-27 results; limited review report by auditors

Q1 FY2026-27 results

  • Board approves unaudited quarterly results for quarter ended June 30, 2026.
  • Limited Review Report by auditors on Q1 2026 unaudited results.
Filed 13:50View Source
28 Jul 20261 filing
Board Meeting

Krebs Biochemicals to hold Aug 6, 2026 board meeting to consider unaudited Q1 results

Meeting Details

  • Board meeting scheduled for August 6, 2026.
  • Agenda: consider unaudited Q1 2026 results (quarter ended June 30, 2026).

Key Agenda Items

  • Consider and adopt unaudited financial results for the quarter ended June 30, 2026.

Other Notes

  • Trading window closure period noted for insiders.
Filed 10:49View Source
2 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Regulation 74(5) certificate filed; dematerialisation details furnished to exchanges

Certificate status

  • Details of dematerialised/rematerialised securities furnished to all stock exchanges.
  • Certificate confirms furnishing of such details to all stock exchanges.
Filed 15:38View Source
29 May 20261 filing
Company UpdateReg.24(A)-Annual Secretarial Compliance

The Company has enclosed herewith Annual Secretarial Complince Report for the yaer ended 31.03.2026.

Filed 11:05View Source
22 May 20261 filing
Company UpdateNewspaper Publication

The Company has enclosing herewith copy of newspapers advetiement of financial resulst for the quarter and yaer ended 31.03.2026.

Filed 10:27View Source
10 Apr 20261 filing
Company UpdateGeneral

Clarification on price movement

Filed 10:11View Source
7 Apr 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

The Company has enclosing herewith certificate received from RTA under reg 74 (5) of SEBI DP Regulations, 2018 for the quarter ended 31.03.2026.

Filed 10:46View Source
19 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

The Company has enclosinh herewith intimation for closure of trading window for considaration of audited financial results for the 4th quarter and year ended 31.03.2026.

Filed 10:46View Source
10 Feb 20261 filing
Company UpdateNewspaper Publication

The Company has enclosing copy of newspaper advertisement of financial results for the quarter ended 31.12.2025

Filed 11:56View Source
Showing 10 of 26 filings